The US cancer society has lowered the recommended age for bowl cancer screening from 50 to 45. This could benefit RHY in the future with their US GTM strategy.
https://unauthorised investment adv...s-as-us-experts-call-for-younger-testing/amp/
A good summary of the RHY opportunity I found on Twitter "One thing $RHY has going for it is that it has a very low market cap ($19 million, $11m EV), compared to $9,6 billion for Exact Sciences, maker of a faecal colon cancer test. Therefore, if performance is maintained in larger prospective trials, the potential is very material"
on the way to $1, page-17
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 130000 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 12800 | 1 |
View Market Depth
| Last trade - 07.01am 01/10/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable